Aerts; Johannes Maria Franciscus Gerardus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aerts; Johannes Maria Franciscus Gerardus.The latest application filed is for "glycosylated metabolites".

Company Profile

4.11.14

Aerts; Johannes Maria Franciscus Gerardus - Amsterdam NL
AERTS; Johannes Maria Franciscus Gerardus - Leiden NL
Aerts; Johannes Maria Franciscus Gerardus - Netherlands NL
Aerts; Johannes Maria Franciscus Gerardus - Abcoude NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase Grant 10,590,082 - Overkleeft , et al.	2020-03-17
Glycosylated Metabolites App 20190195897 - AERTS; Johannes Maria Franciscus Gerardus ; et al.	2019-06-27
N-(5-((aryl Or Heteroaryl)methyloxy)pentyl)-substituted Iminosugars As Inhibitors Of Glucosylceramide Synthase App 20190144388 - OVERKLEEFT; Herman Steven ; et al.	2019-05-16
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase Grant 10,189,784 - Overkleeft , et al. Ja	2019-01-29
N-(5-((aryl Or Heteroaryl)methyloxy)pentyl)-substituted Iminosugars As Inhibitors Of Glucosylceramide Synthase App 20170226058 - OVERKLEEFT; Herman Steven ; et al.	2017-08-10
Activity based probes (ABPs) interacting with glycosidases Grant 9,056,847 - Aerts , et al. June 16, 2	2015-06-16
ACTIVITY BASED PROBES (ABPs) INTERACTING WITH GLYCOSIDASES App 20130143228 - Aerts; Johannes Maria Franciscus Gerardus ; et al.	2013-06-06
Treatment of cystic fibrosis Grant 8,410,081 - Aerts , et al. April 2, 2	2013-04-02
Novel Anti-inflammatory Pro-drugs App 20100323976 - Aerts; Johannes Maria Franciscus Gerardus ; et al.	2010-12-23
Treatment Of Fabry Disease App 20100144008 - Aerts; Johannes Maria Franciscus Gerardus	2010-06-10
Diagnostic Marker For Fabry Disease App 20100047844 - Aerts; Johannes Maria Franciscus Gerardus	2010-02-25
Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof Grant 7,662,838 - Aerts February 16, 2	2010-02-16
Means and methods for detecting endoglycosidase activity Grant 7,632,654 - Aerts December 15, 2	2009-12-15
Treatment Of Cystic Fibrosis App 20090186862 - Aerts; Johannes Maria Franciscus Gerardus ; et al.	2009-07-23
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors Grant 7,528,153 - Aerts May 5, 2	2009-05-05
Use Of A Deoxynojirimycin Derivative Or A Pharmaceutically Salt Thereof App 20070135487 - AERTS; Johannes Maria Franciscus Gerardus	2007-06-14
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors App 20070066581 - Aerts; Johannes Maria Franciscus Gerardus	2007-03-22
Means and methods for detecting endoglycosidase activity App 20050158814 - Aerts, Johannes Maria Franciscus Gerardus	2005-07-21
Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases Grant 6,896,884 - Aerts May 24, 2	2005-05-24
Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases App 20030087414 - Aerts, Johannes Maria Franciscus Gerardus ; et al.	2003-05-08
Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases App 20020086008 - Aerts, Johannes Maria Franciscus Gerardus	2002-07-04
Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases Grant 5,928,928 - Aerts July 27, 1	1999-07-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.